I-E+ NONOBESE DIABETIC MICE DEVELOP INSULITIS AND DIABETES

被引:115
作者
PODOLIN, PL
PRESSEY, A
DELARATO, NH
FISCHER, PA
PETERSON, LB
WICKER, LS
机构
[1] MERCK SHARP & DOHME LTD,DEPT AUTOIMMUNE DIS RES,RY-80W-107,126 E LINCOLN AVE,RAHWAY,NJ 07065
[2] MERCK SHARP & DOHME LTD,DEPT IMMUNOL RES,RAHWAY,NJ 07065
[3] MERCK SHARP & DOHME LTD,DEPT CELLULAR & MOLEC PHARMACOL,RAHWAY,NJ 07065
关键词
D O I
10.1084/jem.178.3.793
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of type I diabetes in the nonobese diabetic (NOD) mouse is under the control of multiple genes, one or more of which is linked to the major histocompatibility complex (MHC). The MHC class II region has been implicated in disease development, with expression of an I-E transgene in NOD mice shown to provide protection from insulitis and diabetes. To examine the effect of expressing an I-E+ or I-E- non-NOD MHC on the NOD background, three I-E+ and three I-E- NOD MHC congenic strains (NOD.H-2i5, NOD.H-2k, and NOD.H-2h2, and NOD.H-2h4, NOD.H-2i7, and NOD.H-2b, respectively) were developed. Of these strains, both I-E+ NOD.H-2h2 and I-E- NOD.H-2h4 mice developed insulitis, but not diabetes. The remaining four congenic strains were free of insulitis and diabetes. These results indicate that in the absence of the NOD MHC, diabetes fails to develop. Each NOD MHC congenic strain was crossed with the NOD strain to produce I-E+ and I-E- F1 mice; these mice thus expressed one dose of the NOD MHC and one dose of a non-NOD MHC on the NOD background. While a single dose of a non-NOD MHC provided a large degree of disease protection to all of the F1 strains, a proportion of I-E+ and I-E- F1 mice aged 5-12 mo developed insulitis and cyclophosphamide-induced diabetes. When I-E+ F1 mice were aged 9-17 mo, spontaneous diabetes developed as well. These data are the first to demonstrate that I-E+ NOD mice develop diabetes, indicating that expression of I-E in NOD mice is not in itself sufficient to prevent insulitis or diabetes. In fact, I-E- F1 strains were no more protected from diabetes than I-E+ F1 strains, suggesting that other non-NOD MHC-linked genes are important in protection from disease. Finally, transfer of NOD bone marrow into irradiated I-E+ F1 recipients resulted in high incidences of diabetes, indicating that expression of non-NOD MHC products in the thymus, in the absence of expression in bone marrow-derived cells, is not sufficient to provide protection from diabetes.
引用
收藏
页码:793 / 803
页数:11
相关论文
共 57 条
[41]   PREVENTION OF DIABETES IN NONOBESE DIABETIC I-AK TRANSGENIC MICE [J].
SLATTERY, RM ;
KJERNIELSEN, L ;
ALLISON, J ;
CHARLTON, B ;
MANDEL, TE ;
MILLER, JFAP .
NATURE, 1990, 345 (6277) :724-726
[42]   ANTIISLET CELL ANTIBODIES FROM NOD MICE [J].
SUPON, P ;
STECHA, P ;
HASKINS, K .
DIABETES, 1990, 39 (11) :1366-1372
[43]  
SUTHERLAND DER, 1984, T ASSOC AM PHYSICIAN, V97, P80
[44]  
Tochino Y, 1987, Crit Rev Immunol, V8, P49
[45]   GENETIC-ANALYSIS OF AUTOIMMUNE TYPE-1 DIABETES-MELLITUS IN MICE [J].
TODD, JA ;
AITMAN, TJ ;
CORNALL, RJ ;
GHOSH, S ;
HALL, JRS ;
HEARNE, CM ;
KNIGHT, AM ;
LOVE, JM ;
MCALEER, MA ;
PRINS, JB ;
RODRIGUES, N ;
LATHROP, M ;
PRESSEY, A ;
DELARATO, NH ;
PETERSON, LB ;
WICKER, LS .
NATURE, 1991, 351 (6327) :542-547
[46]   HLA-DQ-BETA GENE CONTRIBUTES TO SUSCEPTIBILITY AND RESISTANCE TO INSULIN-DEPENDENT DIABETES-MELLITUS [J].
TODD, JA ;
BELL, JI ;
MCDEVITT, HO .
NATURE, 1987, 329 (6140) :599-604
[47]  
TODD JA, 1992, SPRINGER SEMIN IMMUN, V143, P33
[48]  
Uehira M, 1989, Int Immunol, V1, P209, DOI 10.1093/intimm/1.2.209
[49]  
UNO M, 1991, IMMUNOL LETT, V31, P47
[50]   GENETIC-CONTROL OF DIABETES AND INSULITIS IN THE NONOBESE DIABETIC (NOD) MOUSE [J].
WICKER, LS ;
MILLER, BJ ;
COKER, LZ ;
MCNALLY, SE ;
SCOTT, S ;
MULLEN, Y ;
APPEL, MC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (06) :1639-1654